Arkolith/Insider Trading/LENZ/Form 4

Versant Vantage II GP, L.P.

10% OwnerLENZ Therapeutics, Inc. (LENZ) · full profile →Form 4 · filed Mar 25, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 21, 2024Other(J)598K——842K

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-035951) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML